rs11536869
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_138554.5(TLR4):c.94-1009A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0229 in 152,334 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.023 ( 66 hom., cov: 33)
Consequence
TLR4
NM_138554.5 intron
NM_138554.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.61
Publications
15 publications found
Genes affected
TLR4 (HGNC:11850): (toll like receptor 4) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0229 (3496/152334) while in subpopulation NFE AF = 0.0355 (2414/68028). AF 95% confidence interval is 0.0343. There are 66 homozygotes in GnomAd4. There are 1537 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 66 gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TLR4 | NM_138554.5 | c.94-1009A>G | intron_variant | Intron 1 of 2 | ENST00000355622.8 | NP_612564.1 | ||
| TLR4 | NM_003266.4 | c.-147-645A>G | intron_variant | Intron 1 of 3 | NP_003257.1 | |||
| TLR4 | NM_138557.3 | c.-341+2989A>G | intron_variant | Intron 1 of 1 | NP_612567.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TLR4 | ENST00000355622.8 | c.94-1009A>G | intron_variant | Intron 1 of 2 | 1 | NM_138554.5 | ENSP00000363089.5 | |||
| ENSG00000285082 | ENST00000697666.1 | c.-147-645A>G | intron_variant | Intron 1 of 4 | ENSP00000513391.1 |
Frequencies
GnomAD3 genomes AF: 0.0230 AC: 3500AN: 152216Hom.: 66 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
3500
AN:
152216
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0229 AC: 3496AN: 152334Hom.: 66 Cov.: 33 AF XY: 0.0206 AC XY: 1537AN XY: 74494 show subpopulations
GnomAD4 genome
AF:
AC:
3496
AN:
152334
Hom.:
Cov.:
33
AF XY:
AC XY:
1537
AN XY:
74494
show subpopulations
African (AFR)
AF:
AC:
261
AN:
41582
American (AMR)
AF:
AC:
411
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
185
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5186
South Asian (SAS)
AF:
AC:
40
AN:
4834
European-Finnish (FIN)
AF:
AC:
111
AN:
10620
Middle Eastern (MID)
AF:
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2414
AN:
68028
Other (OTH)
AF:
AC:
58
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
190
380
571
761
951
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
14
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.